Nanoviricides

NNVCNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$36.067 M

$1.42 +1.43%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$9.47M

Loss-making

Shares outstanding

21,595,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#366ApollomicsAPLM$37.1M
#367Lantern PharmaLTRN$36.5M
#368NanoviricidesNNVC$36.1M
#369Serina TherapeuticsSER$36.0M
#370BeyondSpringBYSI$35.8M

Where these numbers come from

Share counts and financials for Nanoviricides are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.